Author

M. M. H. Chowdhury

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:proteomics· 2 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

A. Cantin· 1 shared A. J. I. Quenum· 1 shared A. Mahmud· 1 shared A. Menendez· 1 shared A. Piche· 1 shared C. Rioux-Perreault· 1 shared F. Islam· 1 shared F. Rexhepi· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Cantin

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintApr 13, 2023

SARS-CoV-2 spike antigen-specific B cell and antibody responses in pre-vaccination period COVID-19 convalescent males and females with or without post-covid condition

M.-A. Limoges, A. J. I. Quenum, M. M. H. Chowdhury…·S. Ramanathan

This study examines B cell and antibody responses to SARS-CoV-2 antigens in individuals with and without post-COVID condition (PCC), finding sex-related differences in antibody responses to the spike protein.

DOI 10.1101/2023.04.13.535896

humanproteomics

𝕏 PostBluesky

ImmunologybioRxivPreprintSep 29, 2020

BANCOVID, the first D614G variant mRNA-based vaccine candidate against SARS-CoV-2 elicits neutralizing antibody and balanced cellular immune response

J. C. Baray, M. M. R. Khan, A. Mahmud…·K. Nag

This paper develops and characterizes an mRNA-LNP vaccine candidate targeting the D614G variant of SARS-CoV-2, showing neutralizing antibody and balanced cellular immune responses in preclinical trials.

DOI 10.1101/2020.09.29.319061

mouseproteomics

𝕏 PostBluesky